Transaction in Own Shares

Author of the article: Transaction in Own Shares 11 April 2022 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 11 April 2022 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue:…
Transaction in Own Shares

Author of the article:

Transaction in Own Shares

11 April 2022

• • • • • • • • • • • • • • • •

Shell plc (the ‘Company’) announces that on 11 April 2022 it purchased the following number of Shares for cancellation.

Aggregated information on Shares purchased according to trading venue:

Date of purchase Number of Shares purchased Highest price paid

(GBP)

Lowest price paid

(GBP)

Volume weighted average price paid per Share

(GBP)

Venue
11/04/2022 850,000 £21.7600 £21.2950 £21.5270 LSE
11/04/2022 700,000 £21.7600 £21.2850 £21.5270 BATS (BXE)
11/04/2022 600,000 £21.7600 £21.2850 £21.5274 Chi-X (CXE)

These share purchases form part of the Company’s share buy-back arrangement previously announced on 03 February 2022

In respect of this arrangement, Citigroup Global Markets Limited will make trading decisions in relation to the Company’s securities independently of the Company for a period from 3 February 2022 up to and including 4 May 2022

Any such share purchases will be effected within certain pre-set parameters, and in accordance with the Company’s general authority to repurchase shares, Chapter 12 of the Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (on 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegation Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (on 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.

In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by Citigroup Global Markets Limited on behalf of the Company as a part of the buy-back arrangement is detailed below.

Enquiries

Media International: +44 (0) 207 934 5550

Media Americas: +1 832 337 4335

LEI number of Shell plc: 21380068P1DRHMJ8KU70

Classification: Acquisition or disposal of the issuer’s own shares

Attachment

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease
Read More

Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Author of the article: VANCOUVER, British Columbia — Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative disorders, today announced positive results from a bioequivalence study with ALPHA-1062, a proprietary, delayed release oral tablet formulation in development for the…
Fed should lift rates a full percentage point by mid-year -Waller
Read More

Fed should lift rates a full percentage point by mid-year -Waller

Author of the article: Federal Reserve Governor Christopher Waller on Thursday laid out the case for a “concerted” effort to rein in inflation, calling for raising interest rates a full percentage point by mid-year, starting with a half-percentage-point hike in March if data in coming weeks continues to point to an “exceedingly hot” economy. “I…
Asian stocks mixed after US job gain paves way for rate hike
Read More

Asian stocks mixed after US job gain paves way for rate hike

Author of the article: The Associated Press Joe Mcdonald BEIJING (AP) — Asian stocks were mixed on Monday after strong U.S. jobs data cleared the way for more interest rate hikes and China reported its exports rose by double digits. Shanghai and Tokyo advanced while Hong Kong and Seoul retreated. Oil prices edged higher. Wall…